Literature DB >> 15731256

Analysis of human cytomegalovirus oriLyt sequence requirements in the context of the viral genome.

Eva-Maria Borst1, Martin Messerle.   

Abstract

During the lytic phase of infection, replication of herpesvirus genomes initiates at the lytic origin of replication, oriLyt. Many herpesviruses harbor more than one lytic origin, but so far, only one oriLyt has been identified for human cytomegalovirus (HCMV). Evidence for the existence of additional lytic origins of HCMV has remained elusive. On the basis of transient replication assays with cloned viral fragments, HCMV oriLyt was described as a core region of 1.5 kbp (minimal oriLyt) flanked by auxiliary sequences required for maximal replication activity (complete oriLyt). It remained unclear whether minimal oriLyt alone can drive the replication of HCMV in the absence of its accessory regions. To investigate the sequence requirements of oriLyt in the context of the viral genome, mutant genomes were constructed lacking either minimal or complete oriLyt. These genomes were not infectious, suggesting that HCMV contains only one lytic origin of replication. Either minimal or complete oriLyt was then ectopically reinserted into the oriLyt-depleted genomes. Only the mutant genomes carrying complete oriLyt led to infectious progeny. Remarkably, inversion of the 1.5-kbp core origin relative to its flanking regions resulted in a replication-defective genome. Mutant genomes carrying minimal oriLyt plus the left flanking region gave rise to minifoci, but genomes harboring minimal oriLyt together with the right flanking region were noninfectious. We conclude that the previously defined minimal lytic origin is not sufficient to drive replication of the HCMV genome. Rather, our results underline the importance of the accessory regions and their correct arrangement for the function of HCMV oriLyt.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731256      PMCID: PMC1075693          DOI: 10.1128/JVI.79.6.3615-3626.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Replication of herpes simplex virus DNA.

Authors:  I R Lehman; P E Boehmer
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

2.  Development of a cytomegalovirus vector for somatic gene therapy.

Authors:  E Borst; M Messerle
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

3.  Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity.

Authors:  Eva Maria Borst; Martin Messerle
Journal:  Hum Gene Ther       Date:  2003-07-01       Impact factor: 5.695

4.  High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles.

Authors:  M Cotten; E Wagner; K Zatloukal; S Phillips; D T Curiel; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 5.  Initiation of DNA replication: lessons from viral initiator proteins.

Authors:  Arne Stenlund
Journal:  Nat Rev Mol Cell Biol       Date:  2003-10       Impact factor: 94.444

6.  Replicative forms of human cytomegalovirus DNA with joined termini are found in permissively infected human cells but not in non-permissive Balb/c-3T3 mouse cells.

Authors:  R L LaFemina; G S Hayward
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

7.  The variable 3' ends of a human cytomegalovirus oriLyt transcript (SRT) overlap an essential, conserved replicator element.

Authors:  L Huang; Y Zhu; D G Anders
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.

Authors:  E M Borst; G Hahn; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  A new logic for DNA engineering using recombination in Escherichia coli.

Authors:  Y Zhang; F Buchholz; J P Muyrers; A F Stewart
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

View more
  26 in total

1.  Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Authors:  Montse Gustems; Eva Borst; Chris A Benedict; Carmen Pérez; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Conditional and reversible disruption of essential herpesvirus proteins.

Authors:  Mandy Glass; Andreas Busche; Karen Wagner; Martin Messerle; Eva Maria Borst
Journal:  Nat Methods       Date:  2009-07-05       Impact factor: 28.547

4.  Rho-Associated Coiled-Coil Kinase 1 Translocates to the Nucleus and Inhibits Human Cytomegalovirus Propagation.

Authors:  Erez Eliyahu; Osnat Tirosh; Martina Dobesova; Aharon Nachshon; Michal Schwartz; Noam Stern-Ginossar
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

5.  Host-viral effects of chromatin assembly factor 1 interaction with HCMV IE2.

Authors:  Sung-Bau Lee; Chung-Fan Lee; Derick S-C Ou; Kalpana Dulal; Liang-Hao Chang; Chen-Han Ma; Chien-Fu Huang; Hua Zhu; Young-Sun Lin; Li-Jung Juan
Journal:  Cell Res       Date:  2011-03-29       Impact factor: 25.617

6.  A peptide inhibitor of cytomegalovirus infection from human hemofiltrate.

Authors:  Eva Maria Borst; Ludger Ständker; Karen Wagner; Thomas F Schulz; Wolf-Georg Forssmann; Martin Messerle
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

7.  Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  Future Virol       Date:  2010-01       Impact factor: 1.831

8.  The essential human cytomegalovirus gene UL52 is required for cleavage-packaging of the viral genome.

Authors:  Eva Maria Borst; Karen Wagner; Anne Binz; Beate Sodeik; Martin Messerle
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

9.  Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

Authors:  Luka Cicin-Sain; Ivan Bubić; Margit Schnee; Zsolt Ruzsics; Christian Mohr; Stipan Jonjić; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Essential role for either TRS1 or IRS1 in human cytomegalovirus replication.

Authors:  Emily E Marshall; Craig J Bierle; Wolfram Brune; Adam P Geballe
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.